This Guide provides a comprehensive framework to enhance strategic planning, resource allocation, and performance evaluation, ensuring effective implementation of health programs and improved health outcomes.
These guidelines prescribe data, which is required to be submitted to the National Drug Authority to demonstrate the safety, efficacy and quality of vaccines being applied for market authorization. The guidelines also describe the format (CTD) in which dossiers should be presented in support of the application.